Endotronics Inc said operations atits joint venture with Summa Medical Corp &lt;SUMA.O> has ended.    The company said the venture provided production andpurification services to biotechnology companies on a contractbasis. Endotronics, which is reorganizing under Chapter 11, hasa 75 pct stake in the partnership.    The company said it intends to sell the facility thathoused the operations.    It said it is reviewing the adequacy of a two mln dlrreserve set up in the second quarter ended March 31 for thecarrying value of the facility.    The company said the cessation of the joint venture was thesecond move taken to refocus its operations on theinstrumentation business. The company previously said it was nolonger performing research and development for its health caretechnologies. Reuter&#3;